Schubert & Co
- SEC CIK
- 0001894830
- Latest filing
- Jul 30, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by Schubert & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −5−100.0% | Sold out | Holders |
| Q1 2023 | 5 | $1.00K | <0.1% | −3−37.5% | Reduced | Holders |
| Q4 2022 | 8 | $1.90K | <0.1% | +3+60.0% | Added | Holders |
| Q3 2022 | 5 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 5 | $1.00K | <0.1% | +1+25.0% | Added | Holders |
| Q1 2022 | 4 | $1.00K | <0.1% | −1−20.0% | Reduced | Holders |
| Q4 2021 | 5 | $1.00K | <0.1% | – | No prior filing | Holders |